US EditionMetavac®-RSV mucosal bivalent vaccine candidate protects cotton rats against RSV and HMPV and its production process in serum-free Vero cells is scalable in a 2L bioreactor
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Metavac®-RSV mucosal bivalent vaccine candidate protects cotton rats against RSV and HMPV and its production process in serum-free Vero cells is scalable in a 2L bioreactor
Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (HMPV) are the main etiologic agents of viral bronchiolitis and pneumonia in children and elderly. As Live-Attenuated Vaccines (LAV) can stimulate robust mucosal and cellular responses, we previously engineered an HMPV-based bivalent LAV...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
